Inflation Reduction Act: HHS through CMS announced the first 10 drugs covered under Medicare Part D selected for negotiation.
For the first time, Medicare will be able to negotiate prices directly with drug companies, lowering prices on some of the costliest prescription drugs.
For the first time, thanks to President Biden’s Inflation Reduction Act – the historic law lowering health care costs – Medicare is able to negotiate the prices of prescription drugs. Today, the U.S. Department of Health and Human Services , through the Centers for Medicare & Medicaid Services , announced the first 10 drugs covered under Medicare Part D selected for negotiation.
“For far too long, pharmaceutical companies have made record profits while American families were saddled with record prices and unable to afford life-saving prescription drugs. But thanks to the landmark Inflation Reduction Act, we are closer to reaching President Biden’s goal of increasing availability and lowering prescription drug costs for all Americans,” said HHS Secretary Xavier Becerra.
The Biden-Harris Administration has made lowering prescription drug costs and improving access to innovative therapies a key priority. Alongside other provisions in the new law that increase the affordability of health care and prescription drugs, allowing Medicare to negotiate prescription drug prices will strengthen the program’s ability to serve people with Medicare now and for generations to come.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
HHS selects 10 drugs for government price setting under MedicareThe Biden administration on Tuesday selected 10 drugs that will be part of a historic first round of price negotiation through Medicare, including the blood thinner Xarelto and Type-2 diabetes drugs Jardiance and Januvia.
Read more »
US to name first 10 drugs for Medicare price negotiationThe Biden administration on Tuesday is expected to release its list of 10 prescription medicines that will be subject to the first-ever price negotiations by the U.S. Medicare health program that covers 66 million people.
Read more »
US government names first 10 drugs for Medicare price negotiationThe Biden administration on Tuesday released its list of 10 prescription medicines including blood thinner Eliquis from Bristol Myers Squibb and Pfizer that will be subject to the first-ever price negotiations by the Medicare health program.
Read more »
Biden administration unveils first 10 drugs subject to Medicare price negotiationsThe announcement of the 10 drugs kicks off a Medicare negotiation process that aims to make costly medications more affordable for older Americans.
Read more »
US to name first 10 drugs for Medicare price negotiation By ReutersUS to name first 10 drugs for Medicare price negotiation
Read more »